Evidence map›Paper›PMID 34193921›Full record

ArticleScientific reports2021

The structure-based cancer-related single amino acid variation prediction.

Jia-Jun Liu, Chin-Sheng Yu, Hsiao-Wei Wu, Yu-Jen Chang, Chih-Peng Lin, Chih-Hao Lu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Prediction and validation of nanowire proteins inComputational and structural biotechnology journal · 2025
    Article
  2. Nano letters · 2024
    Article
  3. Article
  4. Predicting Mutational Effects on CaJournal of the American Chemical Society · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Recognition of a Novel Gene Signature for Human Glioblastoma.International journal of molecular sciences · 2022
    Article
  9. Predicting Anticancer Drug Resistance Mediated by Mutations.Pharmaceuticals (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jia-Jun LiuThe Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan.
Chin-Sheng YuDepartment of Information Engineering and Computer Science, Feng Chia University, Taichung, Taiwan.
Hsiao-Wei WuGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Yu-Jen ChangThe Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan.
Chih-Peng LinYourgene Health, New Taipei City, Taiwan.
Chih-Hao LuThe Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan. chlu@mail.cmu.edu.tw.
China Medical University · TWFeng Chia University · TWMinistry of Health and Welfare · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Single amino acid variation (SAV) is an amino acid substitution of the protein sequence that can potentially influence the entire protein structure or function, as well as its binding affinity. Protein destabilization is related to diseases, including several cancers, although using traditional experiments to clarify the relationship between SAVs and cancer uses much time and resources. Some SAV prediction methods use computational approaches, with most predicting SAV-induced changes in protein stability. In this investigation, all SAV characteristics generated from protein sequences, structures and the microenvironment were converted into feature vectors and fed into an integrated predicting system using a support vector machine and genetic algorithm. Critical features were used to estimate the relationship between their properties and cancers caused by SAVs. We describe how we developed a prediction system based on protein sequences and structure that is capable of distinguishing if the SAV is related to cancer or not. The five-fold cross-validation performance of our system is 89.73% for the accuracy, 0.74 for the Matthews correlation coefficient, and 0.81 for the F1 score. We have built an online prediction server, CanSavPre ( http://bioinfo.cmu.edu.tw/CanSavPre/ ), which is expected to become a useful, practical tool for cancer research and precision medicine.

Indexed as

Models, BiologicalNeoplasmsSupport Vector MachineAmino Acid SubstitutionHumansNeoplasm ProteinsNeoplasm Proteins

Identifiers

PMID34193921
PMCPMC8245468
OpenAlexW3173554672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.